478 related articles for article (PubMed ID: 14576095)
1. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.
Wu JA; Kusuma C; Mond JJ; Kokai-Kun JF
Antimicrob Agents Chemother; 2003 Nov; 47(11):3407-14. PubMed ID: 14576095
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin.
Walencka E; Sadowska B; Rózalska S; Hryniewicz W; Rózalska B
Folia Microbiol (Praha); 2006; 51(5):381-6. PubMed ID: 17176756
[TBL] [Abstract][Full Text] [Related]
3. Combinations of lysostaphin with beta-lactams are synergistic against oxacillin-resistant Staphylococcus epidermidis.
Kiri N; Archer G; Climo MW
Antimicrob Agents Chemother; 2002 Jun; 46(6):2017-20. PubMed ID: 12019130
[TBL] [Abstract][Full Text] [Related]
4. Lysostaphin as a potential therapeutic agent for staphylococcal biofilm eradication.
Walencka E; Sadowska B; Rozalska S; Hryniewicz W; Rózalska B
Pol J Microbiol; 2005; 54(3):191-200. PubMed ID: 16450834
[TBL] [Abstract][Full Text] [Related]
5. Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.
Kusuma CM; Kokai-Kun JF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3256-63. PubMed ID: 16048934
[TBL] [Abstract][Full Text] [Related]
6. Effect of Antimicrobial and Physical Treatments on Growth of Multispecies Staphylococcal Biofilms.
Stewart EJ; Payne DE; Ma TM; VanEpps JS; Boles BR; Younger JG; Solomon MJ
Appl Environ Microbiol; 2017 Jun; 83(12):. PubMed ID: 28411222
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.
Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D
Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial Resistance Profile of Planktonic and Biofilm Cells of Staphylococcus aureus and Coagulase-Negative Staphylococci.
de Oliveira A; Cataneli Pereira V; Pinheiro L; Moraes Riboli DF; Benini Martins K; Ribeiro de Souza da Cunha Mde L
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598130
[TBL] [Abstract][Full Text] [Related]
9. Effect of sub-lethal doses of vancomycin and oxacillin on biofilm formation by vancomycin intermediate resistant Staphylococcus aureus.
Mirani ZA; Jamil N
J Basic Microbiol; 2011 Apr; 51(2):191-5. PubMed ID: 20967790
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of gallium maltolate against Staphylococci in logarithmic, stationary, and biofilm growth phases: comparison of conventional and calorimetric susceptibility testing methods.
Baldoni D; Steinhuber A; Zimmerli W; Trampuz A
Antimicrob Agents Chemother; 2010 Jan; 54(1):157-63. PubMed ID: 19805560
[TBL] [Abstract][Full Text] [Related]
11. Combination antimicrobial therapy: in vitro synergistic effect of anti-staphylococcal drug oxacillin with antimicrobial peptide nisin against Staphylococcus epidermidis clinical isolates and Staphylococcus aureus biofilms.
Sharafi T; Ghaemi EA; Rafiee M; Ardebili A
Ann Clin Microbiol Antimicrob; 2024 Jan; 23(1):7. PubMed ID: 38245727
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from hospitals in Beijing, China.
Yang XY; Li CR; Lou RH; Wang YM; Zhang WX; Chen HZ; Huang QS; Han YX; Jiang JD; You XF
J Med Microbiol; 2007 Jan; 56(Pt 1):71-76. PubMed ID: 17172520
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci.
El-Azizi M; Rao S; Kanchanapoom T; Khardori N
Ann Clin Microbiol Antimicrob; 2005 Jan; 4():2. PubMed ID: 15638934
[TBL] [Abstract][Full Text] [Related]
14. Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate.
Boyle-Vavra S; Carey RB; Daum RS
J Antimicrob Chemother; 2001 Nov; 48(5):617-25. PubMed ID: 11679550
[TBL] [Abstract][Full Text] [Related]
15. From Antihistamine to Anti-infective: Loratadine Inhibition of Regulatory PASTA Kinases in Staphylococci Reduces Biofilm Formation and Potentiates β-Lactam Antibiotics and Vancomycin in Resistant Strains of
Cutrona N; Gillard K; Ulrich R; Seemann M; Miller HB; Blackledge MS
ACS Infect Dis; 2019 Aug; 5(8):1397-1410. PubMed ID: 31132246
[No Abstract] [Full Text] [Related]
16. Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus.
Climo MW; Ehlert K; Archer GL
Antimicrob Agents Chemother; 2001 May; 45(5):1431-7. PubMed ID: 11302806
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus epidermidis biofilms isolated from infected total hip arthroplasty cases.
Nishimura S; Tsurumoto T; Yonekura A; Adachi K; Shindo H
J Orthop Sci; 2006 Jan; 11(1):46-50. PubMed ID: 16437348
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of recombinant lysostaphin-antibiotic combinations toward methicillin-resistant Staphylococcus aureus.
Polak J; Della Latta P; Blackburn P
Diagn Microbiol Infect Dis; 1993; 17(4):265-70. PubMed ID: 8112040
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of telavancin and vancomycin against biofilm-producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis strains.
LaPlante KL; Mermel LA
Antimicrob Agents Chemother; 2009 Jul; 53(7):3166-9. PubMed ID: 19451302
[TBL] [Abstract][Full Text] [Related]
20. Small Molecules Produced by Commensal Staphylococcus epidermidis Disrupt Formation of Biofilms by Staphylococcus aureus.
Glatthardt T; Campos JCM; Chamon RC; de Sá Coimbra TF; Rocha GA; de Melo MAF; Parente TE; Lobo LA; Antunes LCM; Dos Santos KRN; Ferreira RBR
Appl Environ Microbiol; 2020 Feb; 86(5):. PubMed ID: 31862721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
